| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9317300 | Contraception | 2005 | 9 Pages |
Abstract
These findings suggest that P26h is a potential candidate for the development of a contraceptive vaccine in both males and females.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Evemie Dubé, Christine Legaré, Christian Gaudreault, Robert Sullivan,